Nevro Corp. (NVRO)

Name: Nevro Corp. (NVRO) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Nevro Corp. (NVRO)

Stock Card

$5.84

$0.00 (0.00%)

As on 02-Apr-2025 16:27EDT

Market cap

$224 Mln

Revenue (TTM)

$409 Mln

P/E Ratio

P/B Ratio

Div. Yield

0 %

Nevro (NVRO) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 5.84 High: 5.86

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.4 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-4.8
Debt to Equity

1.1
Book Value

$6.1
EPS

$-3
Face value

--
Shares outstanding

38,372,000

10 Years Aggregate

CFO

$-340.96 Mln

EBITDA

$-682.59 Mln

Net Profit

$-623.08 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Nevro (NVRO)	57.0	2.1	57.0	-56.2	-57.6	-42.1	-19.0
BSE Sensex^*	-9.1	1.1	1.2	-4.8	5.8	6.6	10.7
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 02-Apr-2025 | *As on 27-Aug-2026 | #As on 26-Oct-2023

Company	2024	2023	2022	2021	2020	2019	2018
Nevro (NVRO)	-82.5	-45.7	-51.2	-53.2	47.3	202.2	-43.5
S&P Small-Cap 600	7.0	13.9	-17.4	25.3	9.6	20.9	-9.7
BSE Sensex	8.1	18.7	4.4	22.0	15.8	14.4	5.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About Nevro (NVRO)

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza... SCS system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS systems. It also offers Senza HFX iQ platform that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system. In addition, the company provides HFX AdaptivAI, a pain management platform that powers the HFX iQ SCS system, as well as surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is based in Redwood City, California. Read more

Senior VP & CFO

Mr. Roderick H. MacLeod
President, CEO & Director

Mr. Kevin R. Thornal
Headquarters

Redwood City, CA
Website

https://nevro.com

FAQs for Nevro (NVRO)

What is the current share price of Nevro Corp (NVRO) Today?

The share price of Nevro Corp (NVRO) is $5.84 (NYSE) as of 02-Apr-2025 16:27 EDT. Nevro Corp (NVRO) has given a return of -57.56% in the last 3 years.